AI assistant
Sending…
OptimizeRx Corp — Director's Dealing 2022
Aug 30, 2022
33090_dirs_2022-08-30_54dfc579-7ba6-453c-b78b-a6952032d98b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2022-08-26
Reporting Person: Odence-Ford Marion (General Counsel and CCO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-26 | Common Stock | P | 1000 | $15.75 | Acquired | 5000 | Direct |
More from OptimizeRx Corp
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Director's Dealing
2026
Feb 13
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23